Alpha Omega Wealth Management made a bold move by boosting its stake in CVS Health by 23% in Q1, now holding 148,919 shares ...

This was the stock's fourth consecutive day of gains.

Here is how Adaptive Biotechnologies (ADPT) and CVS Health (CVS) have performed compared to their sector so far this year.

KMG Fiduciary Partners LLC dramatically reduced its investment in CVS Health, selling off 88.1% of its shares. The investor ...

CVS Health, once thought of as the ugly duckling of the healthcare industry, is starting to turn things around. Read why CVS ...

With a market cap of $80.4 billion, CVS Health Corporation (CVS) is a leading pharmacy innovation company headquartered in ...

Wells Fargo analyst Stephen Baxter maintained a Buy rating on CVS Health (CVS – Research Report) yesterday and set a price target of $84.00. The company’s shares closed yester ...

Cantor Fitzgerald analyst Sarah James reiterated a Buy rating on CVS Health (CVS – Research Report) today and set a price target of $71.00. The company’s shares opened today a ...

CVS Health (CVS) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some ...

Ratings for CVS Health CVS were provided by 10 analysts in the past three months, showcasing a mix of bullish and bearish ...

Examining the most recent twelve-month performance further highlights ... debt profile and a larger cash cushion compared to CVS. UNH stock has seen a 15% fall, moving from levels of $330 in ...